- Home
- RCKT vs CRNC Comparison
RCKT vs CRNC Comparison
Compare RCKT & CRNC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | RCKT | CRNC |
|---|---|---|
| Founded | 1999 | 2020 |
| Country | United States | United States |
| Employees | 202 | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | EDP Services |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 401.6M | 430.2M |
| IPO Year | N/A | 2019 |
Fundamental Metrics
Financial Performance| Metric | RCKT | CRNC |
|---|---|---|
| Price | $3.04 | $12.96 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 14 | 4 |
| Target Price | ★ $29.73 | $10.25 |
| AVG Volume (30 Days) | ★ 2.0M | 1.2M |
| Earning Date | 05-04-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 96.95 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $251,781,000.00 |
| Revenue This Year | N/A | $27.18 |
| Revenue Next Year | $64.28 | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $2.40 | $5.85 |
| 52 Week High | $5.45 | $13.74 |
Technical Indicators
Market Signals| Indicator | RCKT | CRNC |
|---|---|---|
| Relative Strength Index (RSI) | 38.89 | 73.92 |
| Support Level | $2.96 | $10.62 |
| Resistance Level | $3.52 | $13.19 |
| Average True Range (ATR) | 0.19 | 0.87 |
| MACD | -0.01 | 0.22 |
| Stochastic Oscillator | 19.27 | 93.08 |
Price Performance
Historical ComparisonAbout RCKT Rocket Pharmaceuticals Inc.
Rocket Pharmaceuticals Inc is a late-stage biopharmaceutical company. It is focused on the development of gene therapies for rare and devastating pediatric diseases. The pipeline products of the company include RP-A501 for Danaon Disease, RP-L102 for Fanconi Anemia, RP-L201 for Leukocyte Adhesion, RP-L301 for Pyruvate Kinase Deficiency, and RP-L401 for Infantile Malignant Osteopetrosis. It has one reportable segment related to R&D and commercial readiness of its gene therapies.
About CRNC Cerence Inc.
Cerence Inc is a United States-based software company. It is involved in developing mobility-based solutions for drivers and their cars. The customers include all automobile original equipment manufacturers, or OEMs, or their tier 1 suppliers. The company's revenue is generated by selling software licenses and cloud-connected services. Geographically, it derives a majority of its revenue from the United States and also has a presence in Other Americas; Germany; Other Europe, the Middle East, Africa; Japan, and Other Asia-Pacific.